BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 28447417)

  • 41. Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics.
    Saha M; McDaniel JK; Zheng XL
    J Thromb Haemost; 2017 Oct; 15(10):1889-1900. PubMed ID: 28662310
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S
    Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in a renal transplant recipient case report.
    Nieto-Rios JF; Zuluaga-Quintero M; Valencia-Maturana JC; Bello-Marquez DC; Aristizabal-Alzate A; Zuluaga-Valencia GA; Serna-Higuita LM; Arias LF
    J Bras Nefrol; 2021; 43(4):591-596. PubMed ID: 33179720
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Diagnostic and Therapeutic Challenges in Atypical Hemolytic Uremic Syndrome: A Case Report].
    Reis S; Ramos D; Cordinhã C; Gomes C
    Acta Med Port; 2019 Oct; 32(10):673-675. PubMed ID: 31625881
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Wada H; Matsumoto T; Yamashita Y
    Semin Thromb Hemost; 2014 Nov; 40(8):866-73. PubMed ID: 25377323
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thrombotic microangiopathies, thrombotic thrombocytopenic purpura, and ADAMTS-13.
    Chapman K; Seldon M; Richards R
    Semin Thromb Hemost; 2012 Feb; 38(1):47-54. PubMed ID: 22314603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of a New, Rapid, Fully Automated Assay for the Measurement of ADAMTS13 Activity.
    Valsecchi C; Mirabet M; Mancini I; Biganzoli M; Schiavone L; Faraudo S; Mane-Padros D; Giles D; Serra-Domenech J; Blanch S; Trisolini SM; Facchini L; Rinaldi E; Peyvandi F
    Thromb Haemost; 2019 Nov; 119(11):1767-1772. PubMed ID: 31587247
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atypical hemolytic uremic syndrome: a case report.
    Basnayake BMDB; Wazil AWM; Nanayakkara N; Samarakoon SMDK; Senavirathne EMSK; Thangarajah BUEWDR; Karunasena N; Mahanama RMBSS
    J Med Case Rep; 2020 Jan; 14(1):11. PubMed ID: 31928535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Diagnosis and management of thrombotic microangiopathies].
    Matsumoto M
    Rinsho Ketsueki; 2015 Oct; 56(10):2092-9. PubMed ID: 26458449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inherited thrombotic thrombocytopenic purpura mimicking immune thrombocytopenic purpura during pregnancy: a case report.
    Romão de Souza V; Beatriz Cavalcante de Oliveira A; Maria Vanderlei A; Queiroz da Mota Silveira Aroucha A; Pontes Duarte B; Nunes Machado A; Netto Chaer L; Wanderley de Barros Correia C; da Conceição de Barros Correia M; Freire Hazin Costa M
    J Med Case Rep; 2018 Jan; 12(1):15. PubMed ID: 29357939
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hemolytic and uremic syndrome and related thrombotic microangiopathies: Epidemiology, pathophysiology and clinics].
    Rafat C; Coppo P; Fakhouri F; Frémeaux-Bacchi V; Loirat C; Zuber J; Rondeau E
    Rev Med Interne; 2017 Dec; 38(12):817-824. PubMed ID: 28711159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [CME: Diagnostic Approach and Management of Thrombotic Microangiopathy].
    Sutter T; Fehr T; Venzin R
    Praxis (Bern 1994); 2022; 111(14):771-777. PubMed ID: 36285415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does severe ADAMTS13 deficiency in thrombotic microangiopathy rule out complement-mediated atypical hemolytic uremic syndrome.
    Arumugam V; Bhowmick R; Agarwal I; Arumadi M
    Saudi J Kidney Dis Transpl; 2019; 30(3):701-705. PubMed ID: 31249236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura.
    Ruggenenti P; Noris M; Remuzzi G
    Kidney Int; 2001 Sep; 60(3):831-46. PubMed ID: 11532079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A case of hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli after pericardiectomy.
    Tome J; Maselli DB; Im R; Amdahl MB; Pfeifle D; Hagen C; Halland M
    Clin J Gastroenterol; 2022 Feb; 15(1):123-127. PubMed ID: 34677733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thrombotic microangiopathy in a 17-year-old patient: TTP, HUS or a bit of both?
    Gerth J; Busch M; Oyen F; Schneppenheim R; Keller T; Budde U; Groene HJ; Wolf G
    Clin Nephrol; 2007 Dec; 68(6):405-11. PubMed ID: 18184524
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Syndromes of Thrombotic Microangiopathy.
    Shatzel JJ; Taylor JA
    Med Clin North Am; 2017 Mar; 101(2):395-415. PubMed ID: 28189178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
    Williams LA; Marques MB;
    Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.